Administration of metformin in clinical medicine; an updated mini-review on current findings
Metformin is in the biguanide class that has been considered as the treatment for insulin resistance diabetes and polycystic ovarian disease. Many mechanisms have been suggested for it such as inhibition of the mitochondrial respiratory chain and mitochondrial glycerophosphate dehydrogenase, activat...
Main Author: | Mahrang Hedaiaty |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2018-05-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | http://jnephropharmacology.com/PDF/npj-7-61.pdf |
Similar Items
-
Metformin associated lactic acidosis: A case report
by: U.K. Jayasundara, et al.
Published: (2020-06-01) -
Metformin lactic acidosis. Report of two cases
by: Nieto-Ríos, John Fredy, et al.
Published: (2018-04-01) -
Recurrent hypoglycemia secondary to metformin toxicity in the absence of co-ingestions: a case report
by: Sarah Aldobeaban, et al.
Published: (2018-08-01) -
Mechanism and application of metformin in kidney diseases: An update
by: Anni Song, et al.
Published: (2021-06-01) -
Metformin as a cellular protector; a synoptic view of modern evidences
by: Wiernsperger Nicolas
Published: (2015-01-01)